BNBX Key Statistics, Chart & Performance
The current stock price of BNBX is 1.62 USD. In the past month the price decreased by -47.23%.
BNBX Latest News, Press Relases and Analysis
BNBX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 27.08 | 227.87B | ||
| DHR | DANAHER CORP | 30.48 | 165.99B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 200.24 | 60.85B | ||
| IQV | IQVIA HOLDINGS INC | 20.91 | 41.42B | ||
| A | AGILENT TECHNOLOGIES INC | 26.12 | 41.32B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.02 | 29.93B | ||
| WAT | WATERS CORP | 31.23 | 23.61B | ||
| ILMN | ILLUMINA INC | 33.45 | 22.28B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 38.93 | 19.80B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.96 | 16.90B | ||
| TEM | TEMPUS AI INC | N/A | 12.16B | ||
| RVTY | REVVITY INC | 21.23 | 11.53B |
Related stock screener links
About BNBX
Company Profile
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The Company’s differentiated strategy blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space. The firm is also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Company Info
BNB PLUS CORP
50 Health Sciences Drive
Stony Brook NEW YORK US
Employees: 46
Phone: 16312408800
BNB PLUS CORP / BNBX FAQ
Can you describe the business of BNB PLUS CORP?
Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. The company is headquartered in Stony Brook, New York and currently employs 46 full-time employees. The company went IPO on 2001-08-24. The Company’s differentiated strategy blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space. The firm is also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
What is the current price of BNBX stock?
The current stock price of BNBX is 1.62 USD. The price increased by 2.53% in the last trading session.
Does BNBX stock pay dividends?
BNBX does not pay a dividend.
What is the ChartMill technical and fundamental rating of BNBX stock?
BNBX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the expected growth for BNBX stock?
The Revenue of BNB PLUS CORP (BNBX) is expected to grow by 50.26% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for BNB PLUS CORP?
BNB PLUS CORP (BNBX) currently has 46 employees.
What is the outstanding short interest for BNB PLUS CORP?
The outstanding short interest for BNB PLUS CORP (BNBX) is 1.69% of its float.
BNBX Technical Analysis
BNBX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to BNBX. The financial health of BNBX is average, but there are quite some concerns on its profitability.
BNBX Financial Highlights
Over the last trailing twelve months BNBX reported a non-GAAP Earnings per Share(EPS) of -924.25. The EPS increased by 89.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -679.56% | ||
| ROE | -929.59% | ||
| Debt/Equity | 0 |
BNBX Forecast & Estimates
For the next year, analysts expect an EPS growth of 92.97% and a revenue growth 50.26% for BNBX